J van der Woude

2.6k total citations · 1 hit paper
21 papers, 804 citations indexed

About

J van der Woude is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, J van der Woude has authored 21 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in J van der Woude's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (3 papers). J van der Woude is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (6 papers) and Eosinophilic Esophagitis (3 papers). J van der Woude collaborates with scholars based in Netherlands, United States and Belgium. J van der Woude's co-authors include Adriaan van’t Spijker, Lauran Vogelaar, Frances Tse, Silvio Danese, Édouard Louis, Cynthia H. Seow, Jennifer Jones, Grigorios I. Leontiadis, Uma Mahadevan and Brian Bressler and has published in prestigious journals such as Gastroenterology, Annals of the Rheumatic Diseases and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

J van der Woude

20 papers receiving 785 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

2015 311 citations Geoffrey C. Nguyen, Cynthia H. Seow et al. Gastroenterology profile →

Peers

J van der Woude

GENET

IMMUN

EPIDE

PHEOH

SURGE

María Dolores Martin‐Arranz Spain

Amy Marren United States

Adriaan A. van Bodegraven Netherlands

Cathérine Reenaers Belgium

Serban‐Dan Costa Germany

Mark R. Fleisher United States

Marla C. Dubinsky United States

Olga Merino Spain

B Huang Canada

J.‐F. Rahier Belgium

María Dolores Martin‐Arranz Spain

J van der Woude

384 ×0.8

GENET

162 ×0.5

IMMUN

248 ×0.8

EPIDE

102 ×0.3

PHEOH

254 ×1.0

SURGE

Citations per year, relative to J van der Woude J van der Woude (= 1×) peers María Dolores Martin‐Arranz

Countries citing papers authored by J van der Woude

Since Specialization

Citations

This map shows the geographic impact of J van der Woude's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J van der Woude with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J van der Woude more than expected).

Fields of papers citing papers by J van der Woude

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J van der Woude. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J van der Woude. The network helps show where J van der Woude may publish in the future.

Co-authorship network of co-authors of J van der Woude

This figure shows the co-authorship network connecting the top 25 collaborators of J van der Woude. A scholar is included among the top collaborators of J van der Woude based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J van der Woude. J van der Woude is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dwarkasing, Roy S., Jacques J. M. van Dongen, Gwenny M. Fuhler, et al.. (2024). P538 Platelet-rich stroma during surgery for treatment-refractory perianal fistulizing Crohn’s disease: long-term outcomes of a pilot study. Journal of Crohn s and Colitis. 18(Supplement_1). i1050–i1051. 1 indexed citations

Camps, María Teresa, Gerard Dijkstra, Sander van der Marel, et al.. (2024). P190 Identification of clinical risk factors for postoperative endoscopic recurrence in Crohn’s disease: a prospective, multicenter cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i498–i498.

Bruyne, Pauline De, J van der Woude, Dimitris Rizopoulos, et al.. (2024). Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 79(1). 62–75. 3 indexed citations

Ruler, Oddeke van, Laurents Stassen, Gerard Dijkstra, et al.. (2023). Preoperative screening and prehabilitation strategies prior to ileocolic resection in patients with Crohn’s disease are not incorporated in routine care. International Journal of Colorectal Disease. 38(1). 254–254. 2 indexed citations

Woude, J van der, S Schreiber, Laurent Peyrin‐Biroulet, et al.. (2023). P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme. Journal of Crohn s and Colitis. 17(Supplement_1). i646–i649. 2 indexed citations

Borren, Nienke Z., Millie D. Long, J van der Woude, Robert S. Sandler, & Ashwin N. Ananthakrishnan. (2020). P778 Longitudinal trajectory of fatigue in inflammatory bowel disease patients: a prospective study. Journal of Crohn s and Colitis. 14(Supplement_1). S616–S617. 1 indexed citations

Woude, J van der, Gerard Dijkstra, Andrea E. van der Meulen‐de Jong, et al.. (2020). DOP77 Ustekinumab is associated with better effectiveness outcomes when compared with vedolizumab in Crohn’s disease patients with prior anti-TNF failure: comparative effectiveness study from the ICC Registry. Journal of Crohn s and Colitis. 14(Supplement_1). S114–S116. 1 indexed citations

Biemans, Vince, J van der Woude, Gerard Dijkstra, et al.. (2019). P503 Two year experience with vedolizumab in inflammatory bowel disease patients: results of the ICC case series, a nationwide prospective observational cohort study. Journal of Crohn s and Colitis. 13(Supplement_1). S363–S364. 6 indexed citations

Brink, Gertrude van den, Luuk Stapersma, J van der Woude, et al.. (2019). P458 Effect of cognitive behavioural therapy on clinical disease course in adolescents and young adults with inflammatory bowel disease and subclinical anxiety and/or depression: results of a randomised trial. Journal of Crohn s and Colitis. 13(Supplement_1). S340–S341. 1 indexed citations

10.

Woude, J van der. (2018). 450. Inflammatory bowel disease and pregnancy. Pregnancy Hypertension. 13. S14–S14. 1 indexed citations

11.

Heerwaarden, Ronald van, et al.. (2017). SAT0536 Axial alignment of the knee – importance in cartilage repair? high tibial osteotomy vs. distraction. Annals of the Rheumatic Diseases. 76. 978–979. 4 indexed citations

12.

Tio, Darryl, J van der Woude, C.A.C. Prinsen, et al.. (2016). A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures. Journal of the European Academy of Dermatology and Venereology. 31(4). 616–624. 56 indexed citations

13.

Nguyen, Geoffrey C., Cynthia H. Seow, Cynthia Maxwell, et al.. (2015). The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology. 150(3). 734–757.e1. 311 indexed citations breakdown →

14.

Allez, Matthieu, Konstantinos Κarmiris, Édouard Louis, et al.. (2010). Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects. Journal of Crohn s and Colitis. 4(4). 355–366. 278 indexed citations

15.

Vogelaar, Lauran, J van der Woude, & Adriaan van’t Spijker. (2009). The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clinical and Experimental Gastroenterology. 2. 101–101. 72 indexed citations

16.

Breij, Laura M., et al.. (2009). P194 - Assessment of self-efficacy during transition in adolescents with inflammatory bowel disease. Journal of Crohn s and Colitis. 3(1). S87–S87. 5 indexed citations

17.

Damen, Gerard M., Jeroen Hol, L de Ruiter, et al.. (2006). Chemokine Production by Buccal Epithelium as a Distinctive Feature of Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition. 42(2). 142–149. 18 indexed citations

18.

Hommes, Daan W., Bas Oldenburg, R. A. van Hogezand, et al.. (2006). Guidelines for treatment with infliximab for Crohn's disease.. PubMed. 64(7). 219–29. 36 indexed citations

19.

Touw, Daan J., et al.. (1992). Parkinsonisme na toevoeging van fluoxetine aan behandeling met neuroleptica of carbamazepine. Data Archiving and Networked Services (DANS). 136(7). 754–756. 2 indexed citations

20.

Drenth, Joost P.H., et al.. (1965). An automatic integrating microdensitometer. Journal of Scientific Instruments. 42(4). 222–224. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact